Interaction of lithium with 5-HT1B receptors in depressed unipolar patients treated with clomipramine and lithium versus clomipramine and placebo: Preliminary results

Psychiatry Research

Volumn 111, Issue 2-3, 2002, Pages 117-124

  Januel, Dominique ^a,b   Massot, Olivier ^a   Poirier, Marie France ^a   Olié, Jean Pierre ^a   Fillion, Gilles ^a  

^a INSTITUT PASTEUR   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

5 HT1B receptors; Adenylate cyclase; Lithium; Major depression; Serotonin receptors

Indexed keywords

ADENYLATE CYCLASE; CLOMIPRAMINE; CYCLIC AMP; LITHIUM; LITHIUM CARBONATE; N [4 [5 [3 (2 AMINOETHYL) 1H INDOL 5 YL] 1,2,4 OXADIAZOL 3 YL]BENZYL]METHANESULFONAMIDE; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTONINERGIC SYSTEM; THROMBOCYTE;

ADENYLATE CYCLASE; ADULT; ANTIDEPRESSIVE AGENTS; BLOOD PLATELETS; CLOMIPRAMINE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; TREATMENT OUTCOME;

EID: 0037200638     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00136-1     Document Type: Article

References (48)

1. American Psychiatric Association . DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Press, Washington, DC.
2. Austin M.P.V., Souza F.G.M., Goodwin G.M. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. British Journal of Psychiatry. 159:1991;510-514.
3. Blier P., de Montigny C. Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. European Journal of Pharmacology. 113:1985;69-77.
4. Blier P., de Montigny C., Tardiff D. Short term lithium treatment enhances responsiveness of postsynaptic 5-HT1A receptors without altering autoreceptor sensitivity: an electrophysiological study in the rat brain. Synapse. 1:1987;225-232.
5. Brochier T., Pascalis J.G., Lôo H. Le lithium dans le traitement des dépressions résistantes. Encephale. XIX:1993;553-564.
6. Bunney W.E., Garland-Bunney J.R. Mechanism of action of lithium in affective illness: basic and clinical implications. Meltzer H.Y., Psychopharmacology. The Third Generation of Progress. 1987;553-565 Raven Press, New York.
7. Capiello A., McDougle C.I., Delgado P.L., Malison R.T., Jatlowl P., Charney D.S., Heninger R., Price L.H. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. International Clinical Psychopharmacology. 13:1998;191-198.
8. de Montigny C., Grunberg F., Mayer A., Deschenes J.P. Lithium induces rapid relief of depression in tricyclic antidepressants drug non-responders. British Journal Psychiatry. 138:1981;252-256.
9. de Montigny, C., Blier, P., 1992. Potentiation of 5 HT neurotransmission by short term lithium: in vivo electrophysiological studies, Clinical Neuropharmacology 15(Suppl. pt. A).
10. Ebert D., Jaspert A., Murata H., Kaschka W.P. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients. Psychopharmacology. 118:1995;223-225.
11. Ebstein R.P., Belmaker R., Grunhaus L., Rimon R. Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature. 259:(5542):1976;411-413.
12. El-Mallakh R.S. Lithium actions and mechanisms. Progress in Psychiatry. 1996;6-10 American Psychiatric Press.
13. Fagiolini A., Buysse D.J., Frank E., Houck P.R., Luther J.F., Kupfer D.J. Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression. Journal of Clinical Psychopharmacology. 21:2001;474-478.
14. 3H]hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices. Journal of Neurochemistry. 50:1988;195-201.
15. Glue P.W. The effect of lithium an 5 HT-medicated neuroendocrine responses and platelet 5 HT receptors. Psychopharmacology. 90:1986;384-402.
16. Hotta I., Yamawaki S., Segawa T. Long term lithium treatment causes serotonin receptor down regulation via serotonergic presynapses in rat brain. Neuropsychobiology. 16:1986;19-26.
17. Januel D., Galinowski A., Poirier M.F., Aymard N., Olié J.P., Lôo H. Prospective study of antidepressants combined with lithium in unipolar depression; preliminary results. Lithium. 5:1994;253-257.
18. Johanning H., Mellerup E., Plenge P. Serotonin receptors in the brain of rats treated chronically with lithium administrated via food or by intraperitoneal injections. Pharmacology and Toxicology. 70:(1):1992;72-74.
19. Kanof P.D., Johns C., Davidson M., Siever L.J., Coccaro E.F., Davis K.L. Prostaglandin receptor sensitivity in psychiatric disorders. Archives of General Psychiatry. 43:1986;987-993.
20. Katona C.L.E. Lithium augmentation in refractory depression. Psychiatry Developments. 2:1988;153-171.
21. Kofman O., Belmaker R.H. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biological Psychiatry. 34:1993;939-952.
22. Kojima H., Terao T., Yoshimura R. Serotonin syndrome during clomipramine and lithium treatment. American Journal of Psychiatry. 150:(12):1993;1897.
23. Lingjaerde O., Edlund A.H., Gormsen C.A., Gottfries C.G., Haugstad A., Hermann I.L., Hollnagel P., Makimattila A., Rasmussen K.E., Renug J., Robak O.H. The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. Acta Psychiatrica Scandinavica. 50:(2):1974;233-242.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
25. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's actions. Archives of General Psychiatry. 52:1995;531-543.
26. Massot O., Rousselle J.C., Fillion M.P., Januel D., Plantefol M., Fillion G. 5 HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology. 21:1999;530-541.
27. Montgomery S.A., Åsberg M. A new depression rating scale designed to be sensitive to change. British Journal of Psychiatry. 134:1979;382-389.
28. Mork A., Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum and hippocampus from rats treated chronically with lithium. Biological Psychiatry. 26:1989a;279-288.
29. Mork A., Geisler A. The effects of lithium in vitro and ex vivo in brain are exerted by distinct mechanisms. Neuropharmacology. 28:1989b;307-311.
30. Murphy D.L., Donnely C., Moskowitz J. Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Clinical Pharmacology and Therapeutics. 14:1974;810-814.
31. Newman M.E. Serotonin inhibits adenylate cyclase in human platelet membranes. European Journal of Pharmacology. 216:1992;281-285.
32. Newman M.E., Belmaker R.H. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase in membranes from the cerebral cortex of rat. Neuropharmacology. 12:(26):1987;211-217.
33. Nisijima K., Shimizu M., Abe T., Ishiguro T. A case of serotonin induced by concomitant treatment with a low dose trazodone and amitriptyline and lithium. International Clinical Psychopharmacology. 11:(4):1996;289-290.
34. Nixon M.K., Hascoet M., Bourin M., Colombel M.C. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology. 115:1994;59-64.
35. Price L.H., Heninger G.R. Drug therapy: lithium in the treatment of mood disorders. New England Journal of Medicine. 331:1994;591-598.
36. Price L.H., Charney D.S., Heninger G.R. Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry. 143:1986;1387-1392.
37. Price L.H., Charney D.S., Delgado P.L., Heninger G.R. Lithium treatment and serotoninergic function. Archives of General Psychiatry. 46:(7):1989;625-631.
38. Redrobe J.P., Bourin M. Evidence of the activity of lithium on 5 HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology. 141:1999;370-377.
39. Rouillon F., Gorwood P. The use of lithium to augment antidepressant medication. Journal of Clinical Psychiatry. 59:(Suppl. 5):1998;32-39.
40. Salomon Y., Londos C., Rodbell M.A. Highly sensitive adenylate cyclase assay. Analytical Biochemistry. 58:1974;541-548.
41. Siever L.J., Kafka M.S., Targum S., Lake C.R. Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Research. 11:1984;287-302.
42. Schöpf J., Baumann P., Lemarchand T., Rey M. Treatment of endogenous depression resistant to tricyclic antidepressant or related drugs by lithium addition. Results of a placebo controlled double blind study. Pharmacopsychiatry. 22:1989;183-187.
43. Sharp T., Bramwell S.R., Lambert P., Grahame-Smith D.G. Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology. 30:1991;977-984.
44. Song L., Jope R.S. Chronic lithium treatment impairs phosphatidyl inositol hydrolysis in membranes from rat brain regions. Journal of Neurochemistry. 58:1992;2200-2206.
45. Souza F.G.M., Goodwin G.M. Lithium treatment and prophylaxis in unipolar depression; a meta-analysis. British Journal of Psychiatry. 158:1991;575-666.
46. Sternbach H. The serotonin syndrome. American Journal of Psychiatry. 148:1991;705-713.
47. Weizman R., Gur E., Laor N., Reiss A., Muller U., Yoresh A., Lerer B., Newman M.E. Platelet adenylate cyclase activity in Israeli victims of Iraqi Scud missile attacks with post-traumatic stress disorder. Psychopharmacology. 114:1994;509-512.
48. Zall H., Therman P.G., Myers J.M. Lithium carbonate: a clinical study. American Journal of Psychiatry. 125:1968;549-555.